Anika Therapeutics, Inc. (NASDAQ:ANIK) Position Reduced by HighTower Advisors LLC
HighTower Advisors LLC reduced its position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK – Free Report) by 15.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 13,353 shares of the biotechnology company’s stock after selling 2,530 shares during the quarter. HighTower Advisors […]
